The fractal dimension of star-forming regions at different spatial scales in M33

We study the distribution of stars, HII regions, molecular gas, and individual giant molecular clouds in M33 over a wide range of spatial scales. The clustering strength of these components is systematically estimated through the fractal dimension. We find scale-free behavior at small spatial scales and a transition to a larger correlation dimension (consistent with a nearly uniform distribution) at larger scales. The transition region lies in the range 500-1000 pc. This transition defines a characteristic size that separates the regime of small-scale turbulent motion from that of large-scale galactic dynamics. At small spatial scales, bright young stars and molecular gas are distributed with nearly the same three-dimensional fractal dimension (Df <= 1.9), whereas fainter stars and HII regions exhibit higher values (Df = 2.2-2.5). Our results indicate that the interstellar medium in M33 is on average more fragmented and irregular than in the Milky Way.Comment: 18 pages including 4 figures. Accepted for publication in Ap

Coronal X-Ray Emission from Nearby, Low-Mass, Exoplanet Host Stars Observed by the MUSCLES and Mega-MUSCLES HST Treasury Survey Projects

The high energy X-ray and ultraviolet (UV) radiation fields of exoplanet host stars play a crucial role in controlling the atmospheric conditions and the potential habitability of exoplanets. Major surveys of the X-ray/UV emissions from late-type (K and M spectral type) exoplanet hosts have been conducted by the MUSCLES and Mega-MUSCLES Hubble Space Telescope (HST) Treasury programs. These samples primarily consist of relatively old, ``inactive'', low mass stars. In this paper we present results from X-ray observations of the coronal emission from these stars obtained using the Chandra X-ray Observatory, the XMM-Newton Observatory, and the Neil Gehrels Swift Observatory. The stars effectively sample the coronal activity of low-mass stars at a wide range of masses and ages. The vast majority (21 of 23) of the stars are detected and their X-ray luminosities measured. Short-term flaring variability is detected for most of the fully-convective (M $\leq$ 0.35 M$_{\odot}$) stars but not for the more massive M dwarfs during these observations. Despite this difference, the mean X-ray luminosities for these two sets of M dwarfs are similar with more massive (0.35 M$_{\odot}$ $\leq$ M $\leq$ 0.6 M$_{\odot}$) M dwarfs at $\sim$5 $\times$ 10$^{26}$ erg s$^{-1}$ compared to $\sim$2 $\times$ 10$^{26}$ erg s$^{-1}$ for fully-convective stars older than 1 Gyr. Younger, fully-convective M dwarfs have X-ray luminosities between 3 and 6 $\times$ 10$^{27}$ erg s$^{-1}$.The coronal X-ray spectra have been characterized and provide important information that is vital for the modeling of the stellar EUV spectra.Comment: 39 pages, 15 figures. Accepted for publication in The Astronomical Journa

Managing the Intake of Mineral Supplements that Contain Feed Additives for Beef Calves Grazing Flint Hills Native Grass Pasture is Important

Objective: The objective of this study was to determine the efficacy of mineral supplementation programs that provide a performance-enhancing antibiotic for improving growth of stocker calves grazing native grass pastures in the Flint Hills region of Kansas. Experimental Procedures: A 91-day grazing study was conducted at the Kansas State University Beef Stocker Unit starting in May 2020 utilizing 314 Brahman influenced crossbred steers (739.57 ± 10.54 lb) from Gorman, TX. Steers were randomized and allocated across 18 pastures and randomly assigned to three treatments groups with six replications (paddocks) per group. The treatments assessed consisted of standard free-choice mineral: 1) control, 2) Bambermycin, and 3) Monensin. Cattle were weighed individually on day 0 and day 90. Group pasture pen scale weights were taken and recorded on day 0, 45, and 90. Results: During the initial stages of the trial, the consumption of the Monensin treatment was significantly lower than the other two treatments (P \u3c 0.05). However, by week seven the Monensin consumption was improved yet still lower than the other two treatments. There were no significant differences in average daily gain (P = 0.72) from the mineral supplement over the 91-day trial. The Bottom Line: Over the 91-day trial, there were no significant differences in average daily gain between the mineral treatments

Measuring the Quality of Data Collection in a Large Observational Cohort of HIV and AIDS

The aim of this study was to examine the quality of data collection by studying the validity of collected data. Data were extracted from the clinic charts of two anonymous outpatients by 38 data collectors. A standard for the data to be collected was determined (168 items). The validity was measured by comparing the collected items with the standard; in this way, the percentages of the collected items that were ‘correct’ could be calculated. The percentage ‘correct’ was higher for clinic chart 1 (mean: 83% correct, SD 7%) than for clinic chart 2 (mean: 78% correct, SD 8%). All categories contained incorrectly collected data. These data were divided into missing data, incorrect start-stop dates, and surplus collected data. Almost all start-stop dates would change into ‘correct’ if ‘monthyear’ was considered correct (instead of the standard ‘daymonthyear’). Not all data collectors used specific protocols, and sources other than the written comments were not always checked. This study shows that a high proportion of data was correctly collected. However, the collection of start-stop dates was not optimal, and the collected data included surplus and missing data. Data collectors should be more knowledgeable about HIV disease and trained in the use of difficult protocols, so that they can better recognize what data to collect and how it should be collected. Among physicians, there should be more agreement about what information to record in the charts, to facilitate data extraction for data collectors

Neural correlates of enhanced visual short-term memory for angry faces: An fMRI study

Copyright: © 2008 Jackson et al.Background: Fluid and effective social communication requires that both face identity and emotional expression information are encoded and maintained in visual short-term memory (VSTM) to enable a coherent, ongoing picture of the world and its players. This appears to be of particular evolutionary importance when confronted with potentially threatening displays of emotion - previous research has shown better VSTM for angry versus happy or neutral face identities.Methodology/Principal Findings: Using functional magnetic resonance imaging, here we investigated the neural correlates of this angry face benefit in VSTM. Participants were shown between one and four to-be-remembered angry, happy, or neutral faces, and after a short retention delay they stated whether a single probe face had been present or not in the previous display. All faces in any one display expressed the same emotion, and the task required memory for face identity. We find enhanced VSTM for angry face identities and describe the right hemisphere brain network underpinning this effect, which involves the globus pallidus, superior temporal sulcus, and frontal lobe. Increased activity in the globus pallidus was significantly correlated with the angry benefit in VSTM. Areas modulated by emotion were distinct from those modulated by memory load.Conclusions/Significance: Our results provide evidence for a key role of the basal ganglia as an interface between emotion and cognition, supported by a frontal, temporal, and occipital network.The authors were supported by a Wellcome Trust grant (grant number 077185/Z/05/Z) and by BBSRC (UK) grant BBS/B/16178

A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity

Mutations in LRRK2 are one of the primary genetic causes of Parkinson's disease (PD). LRRK2 contains a kinase and a GTPase domain, and familial PD mutations affect both enzymatic activities. However, the signaling mechanisms regulating LRRK2 and the pathogenic effects of familial mutations remain unknown. Identifying the signaling proteins that regulate LRRK2 function and toxicity remains a critical goal for the development of effective therapeutic strategies. In this study, we apply systems biology tools to human PD brain and blood transcriptomes to reverse-engineer a LRRK2-centered gene regulatory network. This network identifies several putative master regulators of LRRK2 function. In particular, the signaling gene RGS2, which encodes for a GTPase-activating protein (GAP), is a key regulatory hub connecting the familial PD-associated genes DJ-1 and PINK1 with LRRK2 in the network. RGS2 expression levels are reduced in the striata of LRRK2 and sporadic PD patients. We identify RGS2 as a novel interacting partner of LRRK2 in vivo. RGS2 regulates both the GTPase and kinase activities of LRRK2. We show in mammalian neurons that RGS2 regulates LRRK2 function in the control of neuronal process length. RGS2 is also protective against neuronal toxicity of the most prevalent mutation in LRRK2, G2019S. We find that RGS2 regulates LRRK2 function and neuronal toxicity through its effects on kinase activity and independently of GTPase activity, which reveals a novel mode of action for GAP proteins. This work identifies RGS2 as a promising target for interfering with neurodegeneration due to LRRK2 mutations in PD patient

Atherosclerotic calcification is related to a higher risk of dementia and cognitive decline

Background: Longitudinal data on the role of atherosclerosis in different vessel beds in the etiology of cognitive impairmen